Maykin Ho
CIK 1646395 · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.95M
Companies
6
Total Filings
43
Lifetime Open-Market Net
-$148.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AGIO | Director | 19,848 | $35.99 | $714.3K | $0 | 16 | 2026-06-23 |
| KYNB | Director | — | $6.97 | — | $0 | 1 | 2026-06-17 |
| BMRN | Director | 35,500 | $62.07 | $2.20M | $0 | 7 | 2026-06-04 |
| NMRA | Director | 20,100 | $1.68 | $33.8K | $0 | 5 | 2026-05-29 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 1,601 | $9.75 | $15.6K | -$148.6K | 9 | 2025-06-06 |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Director | 6,612 | — | — | $0 | 3 | 2017-09-11 |
Recent Filings · Page 3 of 5
43 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-23 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +15,777 | $0 | EDGAR |
| 2022-05-26 | BMRN | Grant (A) | +4,980 | $0 | EDGAR |
| 2022-05-24 | AGIO | Exer (M) | +1,585 | $0 | EDGAR |
| 2021-06-02 | AGIO | Exer (M) | +1,686 | $0 | EDGAR |
| 2021-05-28 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +4,700 | $0 | EDGAR |
| 2021-05-27 | BMRN | Grant (A) | +5,120 | $0 | EDGAR |
| 2021-05-24 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2021-02-19 | BMRN | Grant (A) | +2,350 | $0 | EDGAR |
| 2020-06-08 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +4,700 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.